Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform

Tumor stroma and growth factors provide a survival environment to tumor cells and can modulate their chemoresistance by dysregulating several signal pathways. In this study, we fabricated a three-dimensional (3D) microfluidic chip using polydimethylsiloxane (PDMS) to investigate the impact of hepatocyte growth factor (HGF) from cancer-associated fibroblasts (CAF) on the Met/PI3K/AKT activation, glucose regulatory protein (GRP78) expression and the paclitaxel-induced A549 cell apoptosis. With a concentration gradient generator, the assembled chip was able to reconstruct a tumor microenvironment in vitro. We found high levels of HGF in the supernatants of CAF and the CAF matrix from the supernatants of activated HFL1 fibroblasts or HGF enhanced the levels of Met, PI3K and AKT phosphorylation and GRP78 expression in A549 cells cultured in a 3D cell chamber, which was abrogated by anti-HGF. Inhibition of Met attenuated the CAF matrix-enhanced PI3K/AKT phosphorylation and GRP78 expression while inhibition of PI3K reduced GRP78 expression, but not Met phosphorylation in A549 cells. Inhibition of GRP78 failed to modulate the CAF matrix-enhanced Met/PI3K/AKT phosphorylation in A549 cells. Furthermore, inhibition of PI3K or GRP78 enhanced spontaneous and paclitaxel-induced A549 cell apoptosis. Moreover, treatment with the CAF matrix inhibited spontaneous and medium or high dose of paclitaxel-induced A549 cell apoptosis. Inhibition of PI3K or GRP78 attenuated the CAF matrix-mediated inhibition on paclitaxel-induced A549 cell apoptosis. Our data indicated that HGF in the CAF matrix activated the Met/PI3K/AKT and up-regulated GRP78 expression, promoting chemoresistance to paclitaxel-mediated apoptosis in A549 cells. Our findings suggest that the microfluidic system may represent an ideal platform for signaling research and drug screening.

[1]  Qi Wang,et al.  Microfluidic chip-based technologies: emerging platforms for cancer diagnosis , 2013, BMC Biotechnology.

[2]  Amy S. Lee.  The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. , 2005, Methods.

[3]  Sanjeev Gupta,et al.  Targeting the endoplasmic reticulum-stress response as an anticancer strategy. , 2009, European journal of pharmacology.

[4]  William Pao,et al.  Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer , 2009, Proceedings of the National Academy of Sciences.

[5]  E. Edelman,et al.  Stromal Endothelial Cells Directly Influence Cancer Progression , 2011, Science Translational Medicine.

[6]  Guillaume Lambert,et al.  A microfluidic device for continuous cancer cell culture and passage with hydrodynamic forces. , 2010, Lab on a chip.

[7]  A. Lee,et al.  Engineering microscale cellular niches for three-dimensional multicellular co-cultures. , 2009, Lab on a chip.

[8]  H. Xiong,et al.  SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.

[9]  Long Zhao,et al.  Chemotherapy resistance research of lung cancer based on micro-fluidic chip system with flow medium , 2010, Biomedical microdevices.

[10]  S. Groshen,et al.  GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. , 2006, Cancer research.

[11]  M. Tada,et al.  Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells. , 2010, International journal of oncology.

[12]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[13]  Eli J. Weinberg,et al.  In vitro analysis of a hepatic device with intrinsic microvascular-based channels , 2008, Biomedical microdevices.

[14]  Gwo-Bin Lee,et al.  Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.

[15]  Y. Sekido,et al.  Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer , 2009, Clinical Cancer Research.

[16]  M. Noguchi,et al.  Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis. , 2012, Lung cancer.

[17]  Jiang Li,et al.  Application of microfluidic gradient chip in the analysis of lung cancer chemotherapy resistance. , 2009, Journal of pharmaceutical and biomedical analysis.

[18]  Luke P. Lee,et al.  Nanoliter scale microbioreactor array for quantitative cell biology , 2006, Biotechnology and bioengineering.

[19]  H. Hailes,et al.  Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules , 2008, Journal of chemical biology.

[20]  Qi Wang,et al.  Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device , 2013, PloS one.

[21]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[22]  David J Beebe,et al.  3D microchannel co-culture: method and biological validation. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[23]  G. Liang,et al.  miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer , 2012, Oncogene.

[24]  T. Masaki,et al.  Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells , 2008, Journal of experimental & clinical cancer research : CR.

[25]  S. Patierno,et al.  Lung Inflammation, Injury, and Proliferative Response after Repetitive Particulate Hexavalent Chromium Exposure , 2009, Environmental health perspectives.

[26]  R. Salgia,et al.  Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[27]  S. Pun,et al.  A perfusable 3D cell–matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport , 2008, Biotechnology and bioengineering.

[28]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[29]  F. Gao,et al.  Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. , 2011, Oncology reports.

[30]  J. Isaacs,et al.  Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy , 2012, Molecular Cancer Therapeutics.

[31]  K. Itoh,et al.  Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines , 2011, International journal of oncology.

[32]  T. Morgan,et al.  GRP78/BiP is a novel downstream target of IGF‐1 receptor mediated signaling , 2012, Journal of cellular physiology.

[33]  F. Zunino,et al.  Modulation of cell sensitivity to antitumor agents by targeting survival pathways. , 2010, Biochemical pharmacology.

[34]  Wei Wang,et al.  Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells , 2008, BMC Cancer.

[35]  W. Carroll,et al.  Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling. , 2011, Blood.

[36]  J. Blenis,et al.  The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.